BioScienceAccelerated Transformation

Evolution

Narrow Business

BioScience Leader

FUTURE

PAST

• Narrow business focus in:
  • Hemophilia
  • Blood Collection

• Execute growth drivers and accelerate growth

• Generate sales greater than $12 billion by 2010

TRANSFORM

• Key acquisitions and alliances
  • Immuno
  • Cerus

• New technological platforms

REPOSITION

• Broaden BioScience scope
  • NAVA
  • Acambis

• Expand therapeutic areas

• Value upgrade

• Capability building

Previous slide

Next slide

Back to first slide

View graphic version